Primary Article
Role of Antibody‐Coated Bacteria in the Management of Urinary Tract Infections
Abstract
The antibody-coated bacteria (ACB) test was used to localize the site of urinary tract infection in a group of pediatric and adult patients. Duration of treatment of ACB-positive (upper tract) and ACB-negative (lower tract) infections was correlated with rates of recurrence during follow-up for six or more months. Two relapses with the same organism occurred after 29 ACB-negative episodes were treated with a short course of antimicrobials (≤ 14 days). Of patients with ACB-positive infections, all four given similar short-duration therapy experienced relapse with the same organism, but none of nine had relapse after long-duration therapy (≥ 28 days). High cure rates were obtained with ≤ 14 days therapy in ACB-negative infections and with ≥ 28 days therapy in ACB-positive cases. The ACB test promises to be useful in predicting the appropriate duration of antibiotic therapy.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.